Avita Medical | SCHULD



Debt Veränderung Datum
Adcock Ingram Holdings ZAR 280.54M 199.53M 2024-06
Celltrion KRW 2.19T 18.16B 2024-09
Clinuvel Pharmaceuticals AUD 879.78K 189.09K 2024-06
Cochlear AUD 243.7M 37M 2024-06
CSL USD 12.18B 76M 2024-06
Cspc Pharmaceutical CNY 507.33M 118.46M 2024-12
Dianthus Therapeutics USD 1.49M 1.49M 2024-12
Ecofibre AUD 25.49M 285K 2024-06
Kangmei Pharma CNY 253.72M 1.04B 2024-09
Knight Therapeutics CAD 58.22M 109K 2024-09
Laboratorios Farma EUR 114.41M 6.75M 2024-12
Malin Corporation EUR 0 100K 2024-06
Mayne Pharma AUD 38.82M 2.24M 2024-06
Medical Developments International AUD 2.29M 140K 2024-06
Nanosonics AUD 9.3M 1.35M 2024-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 44.74M 12.56M 2024-12
Pacific Edge NZD 3.33M 747K 2024-09
Paradigm Biopharmaceuticals AUD 142.41K 147.91K 2024-06
Pharma Mar EUR 51.08M 1.99M 2024-12
Polynovo AUD 15.38M 49K 2024-06
PYC Therapeutics AUD 1.11M 568.59K 2024-06
Qiagen NV USD 1.39B 528.29M 2024-12
Ramsay Health Care AUD 11.26B 317.4M 2024-12
ResMed USD 672.76M 4.71M 2024-12
Sartorius EUR 4.53B 98.7M 2024-09
Sino Biopharmaceutical CNY 9.71B 33.98M 2024-12
Telix Pharmaceuticals AUD 581.45M 559.3M 2024-12
Tilray USD 351.72M 15.26M 2024-11
Zz Pientze Pharmaceu 1.18B 115.85M 2024-09



Avita Medical SCHULD - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.